The Inflammation Compass™ for
Your Practice
Offer your members the most advanced cellular therapy monitoring available — proprietary whole-blood RNA sequencing across 3 Health Domains (Activation, Antiviral Response, and Resolution) plus cellular deconvolution from our CLIA-certified Philadelphia laboratory.
CLIA-Certified
Philadelphia, PA
10 Core Pathways
3 Health Domains + Deconvolution
Mobile Phlebotomy
42-state coverage
Cloud Dashboard
Secure clinician portal
Clinical Advantages for
Modern Practices
Designed by clinicians and molecular biologists to solve the real-world challenges of GLP-1 therapy management.
Differentiate Your Practice
Biomeme Labs is the first laboratory dedicated to longitudinal mRNA gene expression profiling for GLP-1 therapy monitoring. Provide your members a level of insight no competitor can match — real-time transcriptomic data that reveals how their cellular pathways are actively responding to treatment.
Improve Member Outcomes
Objective cellular evidence during weight stalls and plateaus. Detection of persistent inflammasome activation, myeloid over-recruitment, and innate immune pathway shifts long before standard blood chemistry changes. Our panels give you the clinical intelligence to evaluate whether systemic immune calming is actively occurring, providing biological clarity even when clinical metrics or bathroom scales appear unchanged.
Reduce Clinical Liability
Documented, structured monitoring creates a defensible clinical record. All results are generated from a CLIA-certified laboratory with full chain-of-custody documentation, validated assays, and proficiency-tested processes. Structured molecular monitoring provides objective documentation of cellular response at defined protocol intervals to support your clinical evaluations.
Revenue Opportunity
GLP-1 monitoring panels are cash-pay wellness services — no insurance pre-authorization, no claim denials. Each member on therapy represents a recurring testing cadence across a structured 4-node program — a 2-node baseline package plus ongoing continuous monitoring. For practices already prescribing Ozempic, Wegovy, Mounjaro, or Zepbound, structured monitoring is a natural service extension that deepens member relationships and increases per-member revenue.
Clinical Trial Evidence: Anti-Inflammatory Kinetics
Prescribers understand that GLP-1 medicines lower systemic inflammation. The critical clinical insight is that incretin anti-inflammatory kinetics operate on a distinct biological timescale from weight loss.
Key Landmark Trial Data: Systemic Incretin Response
Peer-reviewed randomized controlled trials and meta-analytic evidence across semaglutide, tirzepatide, and exenatide
| Trial & Citation | Design & Population | Inflammatory Findings | Evidence Level |
|---|---|---|---|
|
SELECT hs-CRP Analysis Plutzky et al., Circulation 2026 | Semaglutide 2.4 mg vs placebo, n=17,604, established CVD, up to 208 wks | hs-CRP −37.8% at wk 104; early reduction of −12% at wk 4 and −19% at wk 8; reductions observed even in patients with minimal or no weight loss | Established (Prespecified Secondary) |
|
Exenatide PBMC RCT Chaudhuri et al., JCEM 2012 | Exenatide 10 mcg BID vs saline, n=24, type 2 diabetes, 12 wks | Mononuclear cell TLR2, TLR4, TNF-α, and IL-1β mRNA along with NF-κB activity reduced by 16–31% with no weight loss | Established (Mechanistic Human RCT) |
|
STEP 1, 2, 3 Exploratory Verma et al., Lancet DE 2023 | Semaglutide 2.4 mg vs placebo, 68 wks, overweight/obesity with & without T2D | hs-CRP −44%, −39%, −48% vs placebo; strongly correlated with waist, weight, and HOMA-IR declines | Established (Pooled RCTs) |
|
STEP-HFpEF Kosiborod et al., NEJM 2023 | Semaglutide vs placebo, n=529, heart failure with preserved ejection fraction | CRP −43.5% vs −7.3% for placebo; robust symptom reduction and improved 6-minute walk distance | Established (Phase 3 RCT) |
|
Tirzepatide Cardiometabolic Wilson 2022; Masson 2025 | Phase 2b post hoc (n=316) and 8-study systematic meta-analysis | Dose-dependent hs-CRP −33% to −36%; endothelial adhesion molecules ICAM-1 and YKL-40 significantly reduced; IL-6 −18% | Established (Phase 2/3 & Meta-Analysis) |
|
SURMOUNT-OSA Mediation Malhotra et al., Nat Med 2026 | Tirzepatide vs placebo, OSA with obesity, 52 wks | Statistical mediation analysis confirmed that systemic hs-CRP reduction occurred independently of weight loss | Emerging (Mediation Analysis) |
Three Core Questions Prescribers Ask About Whole-Blood RNA
“Why test inflammation if my patient is already losing weight?”
Because systemic inflammation and weight loss decouple early and often. In SELECT, hs-CRP fell by 12% at 4 weeks and 19% at 8 weeks with only 2–3% weight loss, and fell in non-losers. In Chaudhuri 2012, leukocyte NF-κB and TLR expression plummeted with zero weight change.
When a patient hits a 6-week weight plateau or experiences titration delays, whole-blood transcriptomics provides objective evidence that metabolic quieting and tissue restoration are actively proceeding — preventing premature discontinuation.
“What does blood RNA measure if leukocytes lack GLP-1 receptors?”
Human peripheral leukocytes express virtually no GLP-1R (<10% PBMC transcript detection; Zobel 2021). The Inflammation Compass™ does not measure drug binding. As elucidated by Wong & Drucker (J Clin Invest 2025; Cell Metab 2024), incretin anti-inflammatory action is mediated centrally: brain GLP-1R engagement orchestrates efferent autonomic calming to spleen and liver.
Concurrently, decompression of visceral adipocytes ceases chronic TNF-α/IL-6 spillover, and improved gut barrier integrity cuts portal endotoxemia. Leukocytes integrate these systemic cues into altered transcription programs.
“Why whole-transcriptome RNA instead of solitary hs-CRP?”
Serum hs-CRP is an integrative liver acute-phase protein driven by IL-6 with a 19-hour half-life, 30–50% biological variability, and 100-fold swings from intercurrent colds or exercise. It confirms the alarm went off, but cannot attribute pathways.
Whole-transcriptome profiling decomposes systemic inflammation into 3 Health Domains (Activation, Antiviral, Resolution) plus Cellular Deconvolution. It separates viral challenges from metabolic therapy, detects active tissue resolution (stop and clean), and decouples cell counts from cell activation states.
High-Complexity Wet-Lab & Bioinformatics Pipeline
The Inflammation Compass™ is processed under rigorous high-complexity molecular testing protocols at our CLIA-certified facility in Philadelphia, PA (CLIA ID # 39D2229561).
Specimen Stabilization
PAXgene® Blood RNA
Venous blood is drawn into specialized PAXgene tubes containing chemical RNA stabilizers that immediately lyse cells and inactivate RNases, locking the transcriptomic state at venipuncture and preventing ex vivo gene induction during ambient transport.
Sequencing Platform
Illumina NovaSeq
Total RNA undergoes DNA digestion, globin mRNA and ribosomal RNA depletion, and ERCC spike-in control addition. High-throughput stranded libraries are sequenced at ∼30 million paired-end reads (2×150 bp) on Illumina NovaSeq instruments.
Bioinformatics Engine
STAR / featureCounts / TPM
Quality-filtered reads are aligned via STAR to the human GRCh38 reference build, quantified with featureCounts, and normalized to Transcripts Per Million (TPM). Multi-stage QC filters enforce strict read depth, mapping rate, and duplicate thresholds.
Mathematical Scoring
Within-Sample Rank Scoring
Modules are scored within each sample by relative rank against the Chaussabel blood framework and Biomeme's ∼2,500 whole-blood reference cohort. Rank-based scoring renders the readout immune to library batch variation and platform drift.
What We
Provide
A comprehensive laboratory partnership — from assay execution to result delivery. We handle the molecular diagnostics so you can focus on individualized care.
The Inflammation Compass™ Platform
A structured testing program using recurring whole-blood mRNA gene expression profiling to track cellular response throughout treatment. Track innate myeloid activation, inflammasome assembly, and regulatory resolution at the transcriptomic level across your members' health optimization journeys.
Whole-Blood Transcriptomic Panels
Our proprietary molecular layer — whole-transcriptome RNA sequencing (~30M paired-end reads on Illumina NovaSeq) organized into 3 Health Domains: Activation (7 pathways: innate danger sensing, IL-1 signaling, neutrophil/monocyte deployment, platelet containment, and oxidative programs), Antiviral Response (Type I interferon cascade), and Resolution (2 pathways: stop & stand down, tissue clearance machinery), plus cellular deconvolution (“census plus orders”). This is the objective data that distinguishes true systemic therapeutic responders at the cellular level.
Cloud-Based Results Dashboard
Secure results portal with longitudinal member tracking. View current results, compare against prior panels, and monitor trends across your entire member population. Download clear, comprehensive clinical reports for seamless consultation with your members.
Full Chain-of-Custody Documentation
Every sample is tracked from collection through result delivery with complete chain-of-custody documentation. Barcode-verified accessioning, temperature-controlled transport protocols, and auditable processing records ensure defensible results for your clinical practice.
Integration
Workflow
From onboarding to result delivery — a streamlined process designed to integrate with your existing clinical operations.
Onboard
Practice setup and protocol alignment. We configure your account, establish preferred panel configurations, define collection protocols, and set up your dashboard access. Typical onboarding completes in under one week.
Order
Place panel orders through our secure clinician portal or integrate directly via API. Select from pre-configured panel bundles or customize target combinations. Orders flow directly to our accessioning queue.
Collect
Specimen samples collected at your practice using our provided collection kits, or shipped via our pre-labeled, temperature- controlled specimen transport system for telehealth and remote monitoring workflows.
Report
Results delivered via your secure cloud dashboard with automated notification. Longitudinal tracking shows trends across sequential panels, making member consultations straightforward and objective.
Built to Fit Your
Practice Workflow
Biomeme Labs provides a turnkey transcriptomic testing partnership that integrates seamlessly into your clinical operations. Whether your staff draws samples in-office during routine member visits or you utilize our 42-state mobile phlebotomy network for remote members, we handle specimen accessioning, high-complexity molecular processing, and longitudinal reporting.
All analysis is performed at our CLIA-certified Philadelphia facility, delivering objective cellular evidence directly to your secure clinician dashboard.
Flexible Collection: In-Office or At-Home
Draw blood in-clinic and return via prepaid mailer, or assign at-home mobile phlebotomy for telehealth members.
Objective Pathway Intelligence
Objective gene expression data to support longitudinal immune calming evaluation and cellular response tracking.
Longitudinal Member Reports
Clear, visual 3-domain and pathway reports benchmarking follow-up panels against baseline reference profiles.
CLIA-Certified Facility
High-complexity testing laboratory (ID # 39D2229561), Philadelphia, PA.
Built for Your
Practice Model
Whether you're a brick-and-mortar weight management clinic, a telehealth platform, or a longevity practice — our laboratory services adapt to your workflow.
Weight Management Practices
Position GLP-1 monitoring as a premium service offering. Members on Ozempic, Wegovy, Mounjaro, or Zepbound receive structured baseline and follow-up panels that track metabolic response, inflammation, and body composition signals. Differentiate your practice from competitors who prescribe without monitoring.
- Baseline + follow-up panel cadence
- In-office sample collection
- Cash-pay recurring revenue
Telehealth Platforms
Remote GLP-1 monitoring with mail-in sample collection kits. Members receive pre-labeled, temperature-controlled kits shipped to their home. Results flow directly to your secure cloud dashboard — enabling data-driven virtual consultations without requiring an in-person visit.
- Direct-to-door mail-in kits
- Secure clinician cloud portal
- Downloadable clinical reports
Wellness & Longevity Clinics
Comprehensive metabolic profiling that goes beyond standard labs. Pair routine clinical lab panels with mRNA gene expression data to give your longevity members the deepest possible insight into their metabolic health — covering inflammation, insulin sensitivity, lipid metabolism, and cellular aging pathways.
- Integrates with routine clinical labs
- Longitudinal metabolic tracking
- Premium member experience
Peer-Reviewed Clinical References
Randomized controlled trials, mechanistic immunology studies, and bioinformatics literature underpinning whole-blood transcriptomic monitoring.
Partner with
Biomeme Labs
Schedule a partnership call to discuss integration, pricing, and how our GLP-1 monitoring panels can fit your practice model.